Literature DB >> 16394848

Efficacy of Cyto-Chex blood preservative for delayed manual CD4 testing using Dynal T4 Quant CD4 test among HIV-infected persons in Zambia.

April A Truett1, Andrew Letizia, Evans Malyangu, Frank Sinyangwe, Brandi N Morales, Nancy F Crum, Suzanne M Crowe.   

Abstract

BACKGROUND: Manual CD4 tests such as Dynal T4 Quant (Dynabeads, Dynal Biotech, Oslo, Norway) are less expensive alternatives to flow cytometry in resource-limited countries. Whereas blood preservatives have proven useful for stabilizing blood samples to allow delayed CD4 testing by flow cytometry, they have not been verified for manual tests. A method for preservation of blood prior to manual CD4 testing is needed for long-distance transport or sample batching.
METHODS: Blood from HIV-positive Zambian military beneficiaries was mixed (1:1) with Cyto-Chex (Streck Laboratories, La Vista, NE) blood preservative, and the blood was stored at refrigerated, ambient, and incubator (37 degrees C) temperatures prior to Dynabeads CD4 testing at 0, 3, 6, and 9 days after collection. Baseline flow cytometry and Dynabeads testing without preservative were performed for comparison.
RESULTS: Twenty-seven patient samples were analyzed. Dynabeads vs. flow cytometry had a correlation coefficient (r) of 0.84. There was excellent correlation (r = 0.96) between baseline Dynabeads testing and Cyto-Chex-preserved samples. Refrigerated samples showed strong correlation with baseline Dynabeads (r = 0.93-0.95) on days 3, 6, and 9 without decline in CD4 count (P = 0.73). Samples stored at ambient temperature yielded inferior results (r = 0.76-0.81), with a significant decline in CD4 count by day 3 (P < 0.001). The incubator arm had especially poor correlation (r = 0.30-0.49).
CONCLUSIONS: Addition of Cyto-Chex to peripheral blood (1:1) adequately preserves refrigerated blood samples for up to 9 days for subsequent testing with Dynabeads CD4 test. Cyto-Chex, however, cannot be recommended for delayed Dynabeads CD4 testing with storage at 37 degrees C or ambient temperatures in tropical areas similar to the site of this study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16394848     DOI: 10.1097/01.qai.0000191282.77954.fc

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  3 in total

1.  Integration of semiconductor quantum dots into nano-bio-chip systems for enumeration of CD4+ T cell counts at the point-of-need.

Authors:  Jesse V Jokerst; Pierre N Floriano; Nicolaos Christodoulides; Glennon W Simmons; John T McDevitt
Journal:  Lab Chip       Date:  2008-11-05       Impact factor: 6.799

2.  Multisite evaluation of point of care CD4 testing in Papua New Guinea.

Authors:  Malin Malagun; Gideon Nano; Caroline Chevallier; Ragagalo Opina; Gola Sawiya; Joseph Kivavia; Albina Kalinoe; Kathalina Nathaniel; Oscillah Kaminiel; John Millan; Andrea Carmone; Mary Dini; Theresa Palou; Kum Topma; Evelyn Lavu; Jessica Markby
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

3.  Interlaboratory comparison of the TransFix®/EDTA Vacuum Blood Collection tube with the 5 mL Cyto-Chex® BCT.

Authors:  Daniel Harrison; Rosalie Ward; Sarah Bastow; Andrew Parr; Susan Macro; Paul K Wallace
Journal:  Cytometry B Clin Cytom       Date:  2018-10-24       Impact factor: 3.248

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.